Sunday
S11A DYSLIPIDAEMIA IN TYPE 2 DIABETES: Mx & combination therapy why, when & what?
Managing dyslipidaemia in type 2 is critical to reduce CV risk. Understanding the role of combination therapy in Mx dyslipidaemia in type 2 is important for patient outcomes. Seminar will cover why combination therapy is required, when it is required & what combinations are effective.
Solvay
S11C HIV CLINICAL Mx - update, including drug therapy
HIV natural history & Mx in primary care; presentation & case study covering diagnosis in the primary care setting; natural history of HIV; monitoring the HIV positive patient; antiretroviral therapy for HIV; Rx of HIV complications, & brief overview of post-exposure prophylaxis. The seminar will increase your ability to provide supportive and effective shared care of patients with HIV. Australasian Society for HIV Medicine
S12A ACNE & ROSACEA - Mx update
Review of causation and Mx options for these common conditions incl. oral medication, topical, and light based therapy. Advances in PhotoDynamic Therapy (PDT). Patterns of presentation show that rosacea can mimic other conditions. What’s the difference between acne & rosacea? Why do similar therapies work for each? Australasian College of Cosmetic Surgeons
S12B GP FOOTWEAR ADVICE - different feet and pathologies
Different feet & pathologies require different footwear for exercise, work and play! A panel including a rheumatologist, physiotherapist & podiatrist will discuss various factors affecting functional footwear, such as previous foot injuries, lumbo-pelvic instability and hip and knee OA. The wrong shoe can make walking & physical activity difficult and can aggravate an old injury or exacerbate the pain of OA. A look at the different types of exercises people participate in, & advice for the best footwear solution for your patients’ unique foot shape and medical condition.
Michael Kinchington, Paul Hedger, Jason McClaren & a Rheumatologist (TBA) Inogen
S12C DEMENTIA - behavioural and psychological symptoms
Symptoms occur in 90% of dementia patients. Mx is a challenge and includes pharmacotherapy, psychological interventions and environmental measures. This seminar will address the causes and Mx strategies of BPSD. Pfize
S13A PAEDIATRIC DERMATOLOGY
The differential diagnosis of childhood eczema & includes updates on the barrier function of skin, eczema care plans, parent counselling & steroid & non-steroid Rx options. Steroid selection will be examined in terms of efficacy, safety & compliance across different conditions & childhood ages. Practical tips on creating better Rx guidelines for other health care professionals & parents. In-depth coverage of the role of allergy & practical measures in avoiding allergens. Schering Plough
S13B MACULAR DEGENERATION - moving forward in Rx degeneration
Macular degeneration is an emerging epidemic in people over 50. It’s the main cause of severe vision loss in people over 50 and is becoming increasingly common as the population ages. This session will cover the exciting new Rx modalities and the changing paradigms in the Mx of macular degeneration, including their impact on the patients’ quality of life. It will also discuss the importance of early detection and diagnosis, urgent referral, and prompt Rx of this disease. Novartis Ophthalmics
S13C OPIOIDS - new concepts and hot topics
Opioids remain one of the most challenging & contentious drug groups to prescribe safely and appropriately in the long term for chronic non-cancer pain disorders. There has been an explosion of new information over the past decade that is providing new insights & benefits for best practice in gp. Hormonal effects of opioids, opioid-induced pain sensitisation and driver safety whilst on long-term opioids are just some of the topics where research advances are leading to major clinical implications.
Dr Tim Semple, Pain Mx Centre, Royal Adelaide Hospital.Endorsed by Australian Pain Society & supported by MundiPharma
S14A MEN’S HEALTH UPDATE
1. 1. ChoicesWith 3 PDE5 inhibitors on the market, it is difficult to know which to choose. Highlights of the CHOICES study, a head-to-head comparison in men with ED.
2. 2. Role of the GP in the Rx of erectile dysfunctionInformation on causes, Rx options & barriers to Rx of ED, so that GPs are better equipped to treat ED in their day-to-day practice. The impact of ED on all aspects of a man’s life will be considered, & the medical conditions most likely to be associated with ED. The extent to which men seek Rx from their GP, their level of satisfaction with their discussion with their GP, and their level of adherence to the various Rx options will also be discussed. Eli Lilly
S14B SECONDARY HEALTH ISSUES IN AN AGEING POPULATION
Chances are, if an elderly person goes to the doctor for a checkup they think of screening for cancers & CVS risk factors. Public health efforts have concentrated on identifying & managing the major causes of mortality but a comprehensive health check needs to go beyond these primary “cause of death” health issues & include 2° health issues which can have a substantial impact on quality of life rather than longevity. Many older patients are reluctant to talk to their GPs who are well-positioned to have a positive impact on wellbeing by proactively working with patients on these health-related concerns. These incl. sensory impairments such as loss of visual or hearing acuity, fatigue, continence, declining mobility and mild cognitive impairment. Role of the GP in identifying & managing 2° health issues, & the challenges & opportunities will be discussed.
Professor Kerryn Phelps AudioClinic
S14C HEPATITIS & LIVER CANCER PREVENTION
In Australia liver cancer incidence is rising the fastest of all notifiable cancers over the last decade especially in the Asian population. The seminar will present salient epidemiological aspects of liver cancer in Australia, recent advances in the Rx of chronic viral hepatitis & projections on how this could impact the cancer control effort. Dr Monica Robotin, A/Prof Greg Dore, Dr Stephen Li. NSW Cancer Council
S15A TRAVEL HEALTH & IMMUNISATION - new develop. & what shots?
Approx 24% of the Australian population travel overseas each year. The risk posed by infectious diseases is a downside of travel but there is an increasing array of Rx that can be used in prevention, including vaccines. Travellers need to know the potential risk of travel & measures they can take to reduce those risks. Sanofi Pasteur
S15B OVARIAN CANCER - myths & current developments
Ovarian cancer affects around 1400 women in Australia each year. While survival rates are improving, 70% of women will be diagnosed at an advanced stage of the disease when the cancer has spread and is difficult to treat. Early detection remains a challenge due to vague and common symptoms. A gynaecological oncologist & GP will provide information about symptoms of ovarian cancer, appropriate tests and referral pathways and Rx options that will assist GPs in understanding the disease & its Mx.
National Breast Cancer Centre and OvCa Australia
